92 related articles for article (PubMed ID: 4937974)
1. Allograft prolongation with synthetic progestins.
Turcotte JG; Niederhuber JE; Haines RF; Gikas PW
Transplant Proc; 1971 Mar; 3(1):814-8. PubMed ID: 4937974
[TBL] [Abstract][Full Text] [Related]
2. Comparison of medroxyprogesterone and corticosteroids in the treatment of canine renal allografts.
Macdonald AS; Falvey CF; Chan CC
Can J Surg; 1972 Sep; 15(5):326-31. PubMed ID: 4560407
[No Abstract] [Full Text] [Related]
3. Clinical evaluation of the immunogenicity of horse and rabbit antihuman lymphocyte globulin in renal transplantation.
Cerilli GJ; Miller A; Hattan D
Surg Forum; 1970; 21():250-2. PubMed ID: 4936976
[No Abstract] [Full Text] [Related]
4. Clinical experience with antilymphocyte globulin (ALG) in renal transplantation.
Deodhar SD; Konomi K; Nakamoto S; Kuruvila KC
Transplant Proc; 1971 Mar; 3(1):758-61. PubMed ID: 4937968
[No Abstract] [Full Text] [Related]
5. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
[TBL] [Abstract][Full Text] [Related]
6. Prolongation of canine renal allograft survival by using a synthetic progestin in combination with azathioprine and antithymocyte globulin.
Yellin JA; Enein AA; Goldson H; Hong J; Prince B; Sakai A; Kountz SL
Surg Forum; 1977; 28():309-11. PubMed ID: 364721
[No Abstract] [Full Text] [Related]
7. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific differences in the establishment of tolerance. Tolerogenic effects of lung allografts in rats.
Vriens PW; Nisco SJ; Hoyt EG; Lyu SC; Pierre P; Reitz BA; Clayberger C
Transplantation; 1994 Jun; 57(12):1795-8. PubMed ID: 8016886
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression with medroxyprogesterone acetate.
Turcotte JG; Haines RF; Brody GL; Meyer TJ; Schwartz SA
Transplantation; 1968 Mar; 6(2):248-60. PubMed ID: 4172545
[TBL] [Abstract][Full Text] [Related]
10. The effect of immunosuppressive agents and matching on pulmonary allografts.
Motlagh FA; Dutta SK; Paley N; Karlson KE; Garzon AA
Surg Forum; 1970; 21():196-8. PubMed ID: 4936968
[No Abstract] [Full Text] [Related]
11. Effect of a yeast-respiratory stimulator on imuran treated and untreated dog renal allografts.
Murphy GP; Mirand EA; Williams P; Gaeta JF; Groenewald JH; Grace JT
Surg Forum; 1969; 20():299-301. PubMed ID: 4910604
[No Abstract] [Full Text] [Related]
12. Significant prolongation of animal survival by combined therapy of FR167653 and cyclosporine A in rat renal allografts.
Azuma H; Wada T; Gotoh R; Furuichi K; Sakai N; Yazawa K; Yokoyama H; Katsuoka Y; Takahara S
Transplantation; 2003 Oct; 76(7):1029-36. PubMed ID: 14557748
[TBL] [Abstract][Full Text] [Related]
13. Controlled, double-blind trial of antiplatelet aggregating agents in vascular renal allograft rejection.
Mathew TH; Hogan GP; Lewers DT; Bauer H; Maher JF; Schreiner GE
Transplant Proc; 1971 Mar; 3(1):901-4. PubMed ID: 4937989
[No Abstract] [Full Text] [Related]
14. Skin allograft survival following intrathymic injection of donor bone marrow.
Cober SR; Randolph MA; Lee WP
J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report.
Stevens RB; Mercer DF; Grant WJ; Freifeld AG; Lane JT; Groggel GC; Rigley TH; Nielsen KJ; Henning ME; Skorupa JY; Skorupa AJ; Christensen KA; Sandoz JP; Kellogg AM; Langnas AN; Wrenshall LE
Transplantation; 2008 May; 85(10):1391-9. PubMed ID: 18497677
[TBL] [Abstract][Full Text] [Related]
16. Prolongation of pancreatic islet cell allograft survival by graft pretreatment with antilymphoblast globulin (ALG).
Toledo-Pereyra LH; Gordon DA; MacKenzie GH
Am Surg; 1982 Jun; 48(6):282-6. PubMed ID: 6805380
[TBL] [Abstract][Full Text] [Related]
17. Leflunomide prolongs pulmonary allograft and xenograft survival.
Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
[TBL] [Abstract][Full Text] [Related]
18. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
[TBL] [Abstract][Full Text] [Related]
19. Effects of thalidomide, cyclosporine, and diclofenac on skin allograft survival in rabbits.
Chaves DN; Petroianu A; Alberti LR; Pereira WA
Transplant Proc; 2004 May; 36(4):1018-20. PubMed ID: 15194354
[TBL] [Abstract][Full Text] [Related]
20. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
Yanagawa Y; Sugahara K; Kataoka H; Kawaguchi T; Masubuchi Y; Chiba K
J Immunol; 1998 Jun; 160(11):5493-9. PubMed ID: 9605152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
